Thrombogenicity studies of three different variants of processed bovine pericardium

IRBM

Volumn 29, Issue 4, 2008, Pages 223-230

  Guhathakurta, S ^a,b   Balasubramanian, V ^a   Ananthakrishnan, B ^a,b   Veerappan, S ^b   Balasundari, R ^b   Tata, B V R ^c   Cherian, K M ^b  

^a INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

^b Frontier Life Line Pvt   (India)

^c INDIRA GANDHI CENTRE FOR ATOMIC RESEARCH   (India)

Author keywords

Acellurisation; Bovine pericardium; Confocal microscopy; Decellurization; Microscopie confocale; Microscopie lectronique; P ricarde bovin; Thromboembolie; Thrombogenic; Transmission electron microscopy

Indexed keywords

BIOMATERIAL; FORMALDEHYDE; HEPARIN;

ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; COW; CROSS LINKING; GAMMA RADIATION; HEMOLYSIS; HUMAN; NONHUMAN; PERICARDIUM; RADIATION DOSE; TENSILE STRENGTH; THROMBOGENESIS; THROMBOGENICITY;

ANIMALIA; BOVINAE;

EID: 61349101869     PISSN: 19590318     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rbmret.2007.07.003     Document Type: Article

References (27)

1. Chvapil M., Kronenthal R.L., and van Winkle Jr. W. Medical and surgical applications of collagen. In: Hall D.A., and Jackson D.S. (Eds). International review of connective tissue research, vol. 6 (1970) 1-61 [Chapter 1]
2. Cortellaro M., Cofrancesco E., Boschetti C., Mussoni L., Donati M.B., Cardillo M., et al., for the PLAT Group. Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. Arterioscler Thromb 13 (1993) 1412-1417
3. Eliezer MA, Lydia MM, Virna VR, Carlos FR. Mechanics of biomaterials: vascular graft prostheses. Application of Engineering Mechanics in Medicine, GED, University of Puerto Rico, Mayaguez 2005, Group A: A1-A25.
4. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol 47 8 Suppl (2006) C7-C12
5. Fransson LA, Lewis W. Relationship between anticoagulant activity of heparin and susceptibility to periodate oxidation; Elsevier Science Press, FEBS Lett. 1979; 97(1):119-23.
6. Gao Y., Li N., Fei R., Chen Z., Zheng S., and Zeng X. P-selectin-mediated acute inflammation can be blocked by chemically modified heparin, Ro-Heparin. Mol Cells 19 3 (2005) 350-355
7. Grabenwoger M., Grimm M., Eybl E., Leukauf C., Muller M.M., Plenck Jr. H., et al. Decreased tissue reaction to bioprosthetic heart valve material after glutamic acid treatment. A morphological study. J Biomed Mater Res 26 (1992) 1231-1240
8. Grauss R.W., Hazekamp M.G., Oppenhuizen F., Van Munsteren C.J., Gittenberger-De Groot A.C., and Deruiter M.C. Histological evaluation of decellularised porcine aortic valves: matrix changes due to different decellularisation methods. Eur J Cardiothorac Surg 27 4 (2005) 566-571
9. Griffin M.J., Rinder H.M., Smith B.R., Trace J.B., Kriz N.S., Li C.K., et al. The effects of heparin, protamine, and heparin/protamine reversal on platelet function under conditions of arterial shear stress. Anaesth Analg 93 (2001) 20-27
10. Guhathakurta S., Varghese S., Balasubramanian V., Agarwal R., Murthy B.S., Veerappan S., et al. Technique to process xenogenic tissues for cardiovascular implantation - a preliminary report. Curr Sci 91 8 (2006) 1068-1073
11. Huang Lee L.L.H., Cheung D.T., and Nimni M.E. Biochemical changes and cytotoxicity associated with the degradation of polymeric glutaraldehyde derived cross-links. J Biomed Mater Res 124 (1990) 1185-1201
12. Ishihara T., Ferans V.J., Jones M., Boyce S.W., and Roberts W.C. Structure of bovine parietal pericardium and of unimplanted Ionescu shiley pericardial valvular bioprostheses. J Thorac Cardiovasc Surg 81 (1981) 747-757
13. Kauhanen P., Kovanen P.T., and Lassila R. Coimmobilised native macromolecular heparin Proteoglycans strongly inhibit platelet-collagen interactions in flowing blood. Arterioscler Thromb Vasc Biol 20 (2000) E113-E119
14. Keuren J.F.W., Wielders S.J.H., Driessen A., Verhoeven M., Hendriks M., and Lindhout T. Covalently-bound heparin makes collagen thromboresistant. Arterioscler Thromb Vasc Biol 24 (2004) 613-617
15. Laemmel E., Penhoat J., Warocquier-Clerout R., and Sigot-Luizard M.F. Heparin immobilized on proteins usable for arterial prosthesis coating: growth inhibition of smooth-muscle cells. J Biomed Mater Res 39 3 (1998) 446-452
16. Lassila R., Lindstedt K., and Kovanen P.T. Native macromolecular heparin proteoglycans exocytosed from stimulated rat serosal mast cells strongly inhibit platelet collagen interactions. Arterioscler Thromb Vasc Biol 17 (1997) 3578-3587
17. Love J.W. Cardiac prostheses. In: Lanza R., Langer R., and Chick W. (Eds). Principles of tissue engineering (1997), R.G. Landes Company, New York 365-378
18. Menasche P., Flaud P., Huc Co A., and Piwnica A. Collagen vascular grafts: a step towards improved compliance in small-caliber by-pass surgery: preliminary report. Life Support Syst 2 (1984) 233-237
19. Menasche P., Huc A., Hott M., Lavergne A., Miravet L., and Piwnica A. Selective blockage of collagen calcium-binding sites: new process to decrease bioprosthetic valvular calcification. In: Bodner E., and Yacoub M. (Eds). Proceedings of the third international symposium on biologic and bioprosthetic valves (1986), York Medical Books
20. Poletti L.F., Bird K.F., Marques D., Harris R.B., Suda Y., and Sobel M. Structural aspects of heparin responsible for interactions with Von Willebrand factor. Arterioscler Thromb Vasc Biol 17 5 (1997) 925-931
21. Reidy M.A. Factors controlling smooth muscle cell proliferation. Arch Pathol Lab Med 116 (1992) 1276-1280
22. Rygg IH., Ladefoged J., Jorgensen K., and Elling F. Prevention of protein insudation and the related deterioration of bioprosthetic materials by incorporation of heparin-protein complex. Proceedings of the third international symposium on biologic and bioprosthetic valves (1986), York Medical Books [chapter 49]
23. Vasudev S.C., Chandy T., Sharma C.P., Mohanty M., and Umasankar P.R. Synergistic effect of released aspirin/heparin for preventing bovine pericardial calcification. Artif Organs 24 2 (2000) 129-136
24. Weinberg C.P., and Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science 231 (1986) 397-400
25. Won Lee K., Park K.D., Han D.K., Suh H., Park J.C., and Kim Y.H. Heparinized bovine pericardium as a novel cardiovascular bioprosthesis. Biomaterials 21 (2000) 2323-2330
26. Yanguang Gao, Na Li, Rui Fei1, Zhihong Chen, Sheng Zheng, and Xianlu Zeng. P-Selectin-mediated acute inflammation can be blocked by chemically modified heparin, RO-Heparin. Mol Cells 19 3 (2005) 350-355
27. Zacharia R.K., Kirkman T.R., and Clowes A.W. Mechanism of healing in synthetic grafts. J Vasc Surg 6 (1987) 429-436